The provision of Drugs which have lost or are shortly to lose exclusivity, namely Eculizumab; Icatibant; Nintedanib; Omalizumab; Tocilizumab
- Procurement
- Transitional Drugs 7
- Buyer
- NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Published
- 10 Apr 2026
- Status
- active
- CPV
- —
- Tender period
- —
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a tender notice published via Find a Tender on 10 Apr 2026.
Which procurement does this notice belong to?
It is part of "Transitional Drugs 7", published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust).
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable